Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Braz. j. microbiol ; 49(2): 296-302, Apr.-June 2018. tab, graf
Article in English | LILACS | ID: biblio-889227

ABSTRACT

Abstract The main objective of this study was to demonstrate the antimicrobial potential of the crude extract and fractions of Chenopodium ambrosioides L., popularly known as Santa-Maria herb, against microorganisms of clinical interest by the microdilution technique, and also to show the chromatographic profile of the phenolic compounds in the species. The Phytochemical screening revealed the presence of cardiotonic, anthraquinone, alkaloids, tannins and flavonoids. The analysis by HPLC-DAD revealed the presence of rutin in the crude extract (12.5 ± 0.20 mg/g), ethyl acetate (16.5 ± 0.37 mg/g) and n-butanol (8.85 ± 0.11 mg/g), whereas quercetin and chrysin were quantified in chloroform fraction (1.95 ± 0.04 and 1.04 ± 0.01 mg/g), respectively. The most promising results were obtained with the ethyl acetate fraction, which inhibited a greater number of microorganisms and presented the lowest values of MIC against Staphylococcus aureus and Enterococcus faecalis (MIC = 0.42 mg/mL), Pseudomonas aeruginosa (MIC = 34.37 mg/mL), Paenibacillus apiarus (MIC = 4.29 mg/mL) and Paenibacillus thiaminolyticus (MIC = 4.29 mg/mL). Considering mycobacterial inhibition, the best results were obtained by chloroform fraction against M. tuberculosis, M. smegmatis, and M. avium (MIC ranging from 156.25 to 625 µg/mL). This study proves, in part, that the popular use of C. ambrosioides L. can be an effective and sustainable alternative for the prevention and treatment of diseases caused by various infectious agents.


Subject(s)
Anti-Infective Agents/pharmacology , Bacteria/drug effects , Chenopodium ambrosioides/chemistry , Phenols/pharmacology , Phytochemicals/pharmacology , Plant Extracts/pharmacology , Anti-Infective Agents/chemistry , Anti-Infective Agents/isolation & purification , Chromatography, High Pressure Liquid , Drug Evaluation, Preclinical , Microbial Sensitivity Tests , Phenols/chemistry , Phenols/isolation & purification , Phytochemicals/chemistry , Phytochemicals/isolation & purification , Plant Extracts/chemistry , Plant Extracts/isolation & purification
2.
Acta cir. bras ; 30(12): 812-818, Dec. 2015. tab, graf
Article in English | LILACS | ID: lil-769505

ABSTRACT

ABSTRACT PURPOSE: To evaluate the effect of the Chenopodium ambrosioides L (mastruz) extract for preventing bone loss and bone metabolism in ovariectomized rats. METHODS: Twelve rats were subjected to bilateral ovariectomy for inducing osteoporosis. After surgery, they were divided into two groups: Ovariectomy-control group (G1, n=6), receiving 0.5 ml distilled water by gavage for 30 days, and Ovariectomy plus mastruz group (G2, n=6), receiving 0.5 ml of the hydroalcoholic extract of mastruz at 10% concentration (50mg) daily, for the same period. Then, the blood of the animals was collected for further biochemical analysis (liver function) and tibia and liver were removed for histological and histomorphometric analyses. RESULTS: The cortical bone was significantly larger in the G2 than G1, whereas G1 presented the highest amount of adipocytes in the bone marrow (p<0.05). The blood levels of aspartate aminotransferase, triglycerides and cholesterol were significantly higher, whereas globulin and lactate dehydrogenase were smaller in G2 than G1. CONCLUSION: The hydroalcoholic extract of mastruz has effects on bone metabolism by changing blood proteins and enzymes and preventing both bone loss and the substitution of bone marrow cells by.


Subject(s)
Animals , Female , Bone Density/drug effects , Chenopodium ambrosioides/chemistry , Osteoporosis/prevention & control , Phytotherapy/methods , Plant Extracts/pharmacology , Adipocytes/ultrastructure , Aspartate Aminotransferases/blood , Bone Marrow Cells/metabolism , Bone and Bones/drug effects , Bone and Bones/metabolism , Cholesterol/blood , Femur/ultrastructure , Models, Animal , Osteoporosis/etiology , Ovariectomy/adverse effects , Rats, Wistar , Triglycerides/blood
3.
Rev. Inst. Med. Trop. Säo Paulo ; 49(4): 257-260, Jul.-Aug. 2007. graf, tab
Article in English | LILACS | ID: lil-460235

ABSTRACT

To date, there are no vaccines against Leishmania, and chemotherapy remains the mainstay for the control of leishmaniasis. The drugs of choice used for leishmaniasis therapy are significantly toxic, expensive and with a growing frequency of refractory infections. Because of these limitations, a combination therapy is the better hope. This work demonstrates that the essential oil from Chenopodium ambrosioides shows a synergic activity after incubation in conjunction with pentamidine against promastigotes of Leishmania amazonensis. However, an indifferent effect has been found for combinations of meglumine antimoniate or amphotericin B and the essential oil.


Até hoje não temos vacina contra a Leishmania e a quimioterapia é a indicação para o controle desta doença. Os remédios que hoje utilizamos são tóxicos e muito caros e além disso o resultado não é sempre o desejado. Por isso, uma terapia de combinação é a melhor opção. Este trabalho mostra que o óleo de essência de C. ambrosioides tem atividade sinérgica junto com a pentamidina sobre os promastigotas de L. amazonensis, diferente do resultado da combinação de antimônio de meglumine e anfotericina B e o óleo de essência.


Subject(s)
Animals , Mice , Antiprotozoal Agents/pharmacology , Chenopodium ambrosioides/chemistry , Leishmania/drug effects , Meglumine/pharmacology , Oils, Volatile/pharmacology , Organometallic Compounds/pharmacology , Plant Oils/pharmacology , Amphotericin B/pharmacology , Drug Synergism , Parasitic Sensitivity Tests , Pentamidine/pharmacology
4.
Lima; EsSalud; 2007. 77 p.
Monography in Spanish | LILACS, LIPECS | ID: biblio-1114243
5.
SELECTION OF CITATIONS
SEARCH DETAIL